Anda di halaman 1dari 3

USA Pediatric Proton Therapy Market, Patient Numbers, Forecast By Age & Tumors (36 Cancer

Types Analyzed)

USA Pediatric Proton Therapy Market

Free 10% Customization in this Report

Analyst View:
USA Pediatric Proton Therapy Market has potential to reach close to US$ 350 Million by the
end of year 2021. But its actual market is predicted to be less than even half of this figure.
The difference between this actual and potential market is due to its demand and supply gap.

Report Title:
USA Pediatric Proton Therapy Market, Patient Numbers, Forecast By Age & Tumors (36
Cancer Types Analyzed)

Download full Report:


http://www.renub.com/usa-pediatric-proton-therapy-market-patient-numbers-forecast-by-
age-and-tumors-36-cancer-types-analyzed-1188-p.php

USA Pediatric Proton Therapy Market has potential to reach close to US$ 350 Million by the
end of year 2021. But its actual market is predicted to be less than even half of this figure.
The difference between this actual and potential market is due to its demand and supply gap.
In United States, the cancer incidence among pediatric is rising at rapid pace. USA has
largest and more efficient proton therapy center in world due to long history of its proton
therapy research and huge investment on center development.

Age Group of (1-4) has the Largest Cancer Evidence in USA Pediatric Proton Therapy Market
In this report United States pediatric proton therapy market is divided into five age group (<1)
Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. Out of these age groups (1-4) age group
has largest market.

Ependymoma Cancerous Tumor has the Highest Market among 36 Types of Cancer which has
been studied in the report
The largest treated pediatric patient with proton therapy in USA is Ependymoma which has
almost 15 percent share in United States pediatric proton therapy market. Moreover the
ability of proton therapy to treat numerous types of pediatric cancer in a more efficient way
than traditional radiotherapy has made it preferential choice for pediatric cancer patients.

Renub Research LLP Page 1 of 3


USA Pediatric Proton Therapy Market, Patient Numbers, Forecast By Age & Tumors (36 Cancer
Types Analyzed)

Increasing Cancer Incidence Among Pediatric and Phenomenal Progress in Technological


Development of Proton Therapy Across the Period of Time has made it Key driver for Rapid
Growth in United States
Proton Therapy has gained prominence in such a short period due to continuous development of
cutting-edge technology like intensity-modulated proton therapy (IMPT) and pencil beam
technology. Moreover rising cancer incidence among children in United States reinforced
pediatric proton therapy market for faster growth.

USA Pediatric Proton Therapy Market, Patient Numbers, Forecast By Age & Tumors (36
Cancer Types Analyzed)is the 16th report published by Renub Research on Proton Therapy
Market. This 195 page report with 182 figuresand 3 Tables provides: Pediatric Proton Therapy
Market, Proton Therapy Patient Numbers (both by Age Group and Type of Tumors) Technology
being used at these Proton Therapy Centers. The report also studies the Proton Therapy Sales &
Forecast of four companies IBA, Varian Medical Systems, Mitsubishi and Hitachi.

Type of Tumors Market & Patient Numbers Studied in the Report


1. Glioma, Low Grade 15. Choroid Plexus Hodgkins
2. Glioma, High Grade Carcinoma 28. Lymphoma, Non-
3. Medulloblastoma 16. Retinoblastoma hodgkins
4. Ependymoma 17. Osteosarcoma 29. Leukemia
5. ATRT 18. Ewing Sarcoma 30. Desmoid
6. Germinoma, Pure 19. Rhabdomyosarcoma 31. Melanoma
7. Germ Cell Tumor 20. Other Sarcoma, High 32. Pineal Parenchymal
8. Craniopharyngioma Grade Tumor
9. PNET 21. Other Sarcoma, Low 33.
10. Pineoblastoma Grade Esthesioneuroblastoma
11. 22. Teratoma 34. Angiofibroma
Chordoma/Chondrosarcom 23. Neuroblastoma 35. Extrarenal Rhabdoid
a 24. Ganglioglioma Tumor
12. Meningioma 25. Wilms Tumor 36. Others
13. AVM 26. Carcinoma (non-CPC)
14. Adenoma 27. Lymphoma,

Renub Research LLP Page 2 of 3


USA Pediatric Proton Therapy Market, Patient Numbers, Forecast By Age & Tumors (36 Cancer
Types Analyzed)

Age Group Studied in Report

1. Age Group (<1) Year


2. Age Group (1-4) Year
3. Age Group (5-9) Year
4. Age Group (10-14) Year
5. Age Group (15-18) Year

Key Companies Proton Therapy Sales & Forecast (2010 2021) Covered in this report
1. IBA
2. Varian Medical Systems
3. Mitsubishi
4. Hitachi

Key Questions Answered in the Report?


What is the Pediatric Proton Therapy Market in United States and its growth potential in
Future?
How Many Pediatric Patients are treated by Proton Beam Therapy in United States?
What is the Pediatric Proton Therapy Market by Age Group age group (<1) Year, (1-4) Year,
(5-9) Year, (10-14) Year, (15-18) Year in United States and its Forecast?
How Many Pediatric Proton Therapy Patients treated by Age Group age group (<1) Year, (1-
4) Year, (5-9) Year, (10-14) Year, (15-18) Year in United States and its Forecast?
What is the Pediatric Proton Therapy Market by Tumors (36 Types) in United States and its
Forecast?
How Many Pediatric Proton Therapy Patients treated by different Tumor Type in United
States and its Forecast?
What Type of Technology is being used at Proton Therapy Centers?

Medical Devices Report:


http://www.renub.com/medical-devices-15-c.php

Renub Research - North America Renub Research - Asia


Rajat Gupta Ankit Mishra
225 Kristie Ln, Roswell C 86, Sector 10
Georgia 30076, United States Noida 201301, India

Tel: +1-678-302-0700 Tel: +91-120-421-9822


Email: info@renub.com Email: info@renub.com
www.renub.com www.renub.com

Renub Research LLP Page 3 of 3